Literature DB >> 9094710

The role of Fas in autoimmune diabetes.

A V Chervonsky1, Y Wang, F S Wong, I Visintin, R A Flavell, C A Janeway, L A Matis.   

Abstract

Immunologically privileged sites express Fas ligand (FasL), which protects them from attack by activated T cells that express Fas and die upon contact with FasL. In an attempt to protect nonobese diabetic mice (NOD) from autoimmune diabetes, we made FasL transgenic NOD mice using the beta cell-specific rat insulin-1 promoter. Surprisingly, these transgenic mice showed heightened sensitivity to diabetogenic T cells, which was due to self-destruction of beta cells upon T cell-mediated induction of Fas. Fas-negative NOD(lpr/lpr) animals were resistant to diabetogenic T cells and to spontaneous diabetes. Thus, induction of Fas expression on beta cells and their subsequent destruction constitutes the main pathogenic mechanism in autoimmune diabetes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094710     DOI: 10.1016/s0092-8674(00)80178-6

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  99 in total

Review 1.  The role of apoptosis in the initiation of the autoimmune response in Sjögren's syndrome.

Authors:  M G Humphreys-Beher; A B Peck; H Dang; N Talal
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

Review 2.  The role of self-recognition in receptor repertoire development. Members of the Janeway Laboratory.

Authors:  C A Janeway
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 3.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 4.  Immune mechanisms that regulate susceptibility to autoimmune type I diabetes.

Authors:  B Singh; T L Delovitch
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

5.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

6.  Characterization of a novel functional protein in the pancreatic islet: islet homeostasis protein regulation of glucagon synthesis in α cells.

Authors:  Seh-Hoon Oh; Houda Darwiche; Jae-Hyoung Cho; Thomas Shupe; Bryon E Petersen
Journal:  Pancreas       Date:  2012-01       Impact factor: 3.327

7.  Apoptosis in rat spontaneous chronic pancreatis: role of the Fas and Fas ligand system.

Authors:  S B Su; Y Motoo; M J Xie; N Sawabu
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 8.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

9.  Deletion of Fas protects islet beta cells from cytotoxic effects of human islet amyloid polypeptide.

Authors:  Y J Park; S Lee; T J Kieffer; G L Warnock; N Safikhan; M Speck; Z Hao; M Woo; L Marzban
Journal:  Diabetologia       Date:  2012-02-01       Impact factor: 10.122

Review 10.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.